Karen Krasney
Conseiller Juridique Général chez CAPRICOR THERAPEUTICS, INC.
Fortune : 95 624 $ au 30/06/2024
Profil
Karen G.
Krasney is currently the Director at Cardiovascular Research Foundation.
She also holds the positions of Executive Vice President & General Counsel at Capricor, Inc. and Secretary, Executive VP & General Counsel at Capricor Therapeutics, Inc. Ms. Krasney previously served as the Executive Vice President & General Counsel at Biosensors International Group Ltd.
from 2006 to 2010.
She has a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Los Angeles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2024 | 20 047 ( 0,06% ) | 95 624 $ | 30/06/2024 |
Postes actifs de Karen Krasney
| Sociétés | Poste | Début |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Conseiller Juridique Général | 01/01/2012 |
Cardiovascular Research Foundation
 Cardiovascular Research Foundation Miscellaneous Commercial ServicesCommercial Services The Cardiovascular Research Foundation operates as a civic and social association. The non-profit company is based in New York, NY. The company was founded by Charles A. Simonton. | Directeur/Membre du Conseil | - |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Conseiller Juridique Général | 01/01/2012 |
Anciens postes connus de Karen Krasney
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSENSORS INTERNATIONAL GROUP LTD | Conseiller Juridique Général | 12/03/2010 |
Formation de Karen Krasney
| University of California, Los Angeles | Undergraduate Degree |
| University of Southern California | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Biosensors International Group Ltd.
 Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
Cardiovascular Research Foundation
Cardiovascular Research Foundation Miscellaneous Commercial ServicesCommercial Services The Cardiovascular Research Foundation operates as a civic and social association. The non-profit company is based in New York, NY. The company was founded by Charles A. Simonton. | Commercial Services |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
